NAVIGATE-ESUS: VSP actively recruiting for clinical trial

By vanstrokepr on October 28, 2015

The VSP is now actively recruiting for NAVIGATE-ESUS: Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients with Recent Embolic Stroke of Undetermined Source (ESUS). The trial is funded by Bayer.

For more information visit:

https://clinicaltrials.gov/ct2/show/NCT02313909

Posted in

VGH & UBC Hospital Foundation

Since 1980, VGH & UBC Hospital Foundation has partnered with donors to provide the funds ...

Heart and Stroke Foundation

The Heart and Stroke Foundation is one of Canada’s largest and most effective health charities.

Stroke Information

A stroke is a sudden loss of brain function. It is caused by the interruption ...

South Asian Resources

Research has shown that people of South Asian descent are at greater risk of developing ...

Chinese Resources

The Heart and Stroke Foundation of Canada has translated resources to help Chinese Canadians

View All Posts

Western Stroke Conference: November 28th 2015

The 17th annual Western Stroke Conference will occur on November 28th 2015 at the Rosewood ...

PROPHECY: VSP actively recruiting for local study

VSP has secured a pilot research grant from Boehringer-Ingleheim Canada to conduct PROPHECY: prospective validation ...

DATAS-II: VSP actively recruiting for clinical trial

The VSP is now actively recruiting for DATAS-II: Dabigatran following Transient ischemic attack and minor ...